Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women
NCT ID: NCT01872156
Last Updated: 2017-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
350 participants
INTERVENTIONAL
2013-12-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interventions of Smoking Cessation During Pregnancy
NCT01210118
Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in New Aquitaine.
NCT05355012
Smoking Cessation for Low-Income Pregnant Women
NCT02211430
Smoking Cessation Intervention in Pregnant Women
NCT03024606
Effectiveness of Spirometry as a Motivational Tool to Quit Smoking
NCT01821885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary objectives:
1. To evaluate the effectiveness of an intervention in smoking based on a clinical practice guideline on the part of the primary care professionals on the tobacco abstinence 6 months after the childbirth.
2. The effectiveness of the intervention values on the weight of the newborn child, the number of childbirths pre-term and the perinatal mortality.
3. To study the effectiveness of the intervention in smoking on the maintenance of the breast-feeding to 3 and 6 months.
Method:
Design: cluster randomized controlled trial. Setting: study in Health Centers Primary Care of Area of Madrid Health Service.
Sample size adjusted for design effect: number of smoking women in every branch would be of 350.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention GESTABAC
Intervention based on the "Clinician's Guide to helping Pregnant Women Quit Smoking" on the rates of abstinence of the patients in whom it has been controlled in this period of time, at the end of the pregnancy and after the childbirth.
Intervention GESTABAC
Intervention based on the "Clinician's Guide to helping Pregnant Women Quit Smoking" on the rates of abstinence of the patients in whom it has been controlled in this period of time, at the end of the pregnancy and after the childbirth.
Control Group
The group control will act according to usual management.
Control Group
The group control will act according to usual management.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention GESTABAC
Intervention based on the "Clinician's Guide to helping Pregnant Women Quit Smoking" on the rates of abstinence of the patients in whom it has been controlled in this period of time, at the end of the pregnancy and after the childbirth.
Control Group
The group control will act according to usual management.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pregnant at 20 weeks or less of gestation
* attending her first prenatal visit with any of the participating prenatal care teams (this first prenatal visit takes place usually around 6-12 weeks of pregnancy)
* defining herself as a current cigarette smoker or recent ex-smoker (see below for a definition of these terms)
* being able to meet the requisites of the trial:
* being available for the next 15 months
* defining herself as fluent in reading and speaking Spanish to understand the study procedures and to comply with them
* meeting no exclusion criterion; and
* willing and able to give informed consent for participation in the study
Exclusion Criteria
* active addictions to other psychoactive substances
* involved in any other formal smoking cessation program or in another trial during the study period; or
* does not consent to participate in the study
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gerencia de Atención Primaria, Madrid
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Encarnación Serrano-Serrano, MD
Role: PRINCIPAL_INVESTIGATOR
Gerencia de Atención Primaria, Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gerencia de Atención Primaria
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
An online platform to facilitate communication and dissemination of information between the research group
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SOMAMFYC11/2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.